Meihao Medical Group Co., Ltd.

Meihao Medical Group Co., Ltd.

HHKEX:1947
0.47
HKD
-0.01
(-2.08%)
222.10MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.14
0.14
0.18
0.28
0.12
0.13
0.19
- -
Basic EPS, GAAP
0.03
0.02
0.05
0.06
-0.02
-0.06
-0.03
- -
Free Cash Flow per Basic Share
0.03
0.04
0.05
0.05
- -
-0.03
0.01
- -
Dividend per Share
0.02
0.03
- -
- -
- -
0.01
- -
- -
Book Value per Share
0.03
0.03
0.08
0.3
0.28
0.2
0.18
0.2
Tangible Book Value per Share
0.03
0.03
0.08
0.29
0.27
0.18
0.16
0.18
Basic Weighted Avg Shares
600
600
600
457
600
582
547
584
Sales/Revenue/Turnover
83
85
105
127
74
75
102
- -
Operating Margin (%)
28.9
30.65
42.23
32.38
-14.75
-43.75
-20.05
- -
Depreciation Expense
7
8
11
13
14
14
15
- -
Net Income, GAAP
15
15
32
28
-14
-32
-14
- -
Effective Tax Rate (%)
33.01
38.08
26.31
28.93
- -
- -
- -
- -
Profit Margin (%)
18.55
17.63
30.45
22.33
-18.49
-43.42
-14.1
- -
Working Capital
-6
-4
8
135
114
58
54
58
LT Debt
15
13
35
30
25
25
10
25
Total Equity
20
18
51
178
166
120
107
120
Return on Invested Capital (%)
- -
25.99
37.37
17.83
- -
- -
- -
- -
Return on Capital (%)
- -
30.47
42.25
19.18
- -
- -
- -
- -
Return on Common Equity (%)
- -
78.44
93.65
25
-7.94
-22.79
-12.74
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
ST Debt
9
8
8
LT Borrowings
- -
- -
- -
LT Finance Leases
25
24
25
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
600
600
600
Market Capitalization
237
209
209

Working Capital

CNY

•

in mil. unless spec.
Dec'23
Jun'24
Dec'24
Total Current Assets
152
146
98
Cash, Cash Equivalents & STI
142
130
78
Accounts Receivable, Net
1
1
1
Inventories
3
3
2
Total Current Liabilities
38
44
40
Payables & Accruals
- -
- -
- -
ST Debt
9
8
8
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
76.33%
-11.07%
Free Cash Flow
- -
-7,917.6%
-130.26%
Net Income, GAAP
- -
7.78%
-55.77%
Sales/Revenue/Turnover
- -
8.2%
36.16%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
74
2024
- -
- -
75
2025
- -
- -
102

Semi-annual Earnings Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.02
2024
- -
- -
-0.06
2025
- -
- -
-0.03

Semi-annual Dividends Per Share

CNY

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
0.01
2025
- -
- -
- -

Company Description

CEO
Xiao Min Wang
Full Time Employees
522
Sector
Health services
Industry
Medical/Nursing services
Address
197 Fuqian Street Wenzhou ZJ China 325000
IPO Date
Dec 14, 2022
Business
Meihao Medical Group Co., Ltd. is a medical services company that operates a network of private dental hospitals and clinics in China, focusing on general, reparative, implant, and orthodontic/cosmetic dentistry. The group provides a comprehensive range of dental services through its branded hospital network and related dental facilities, with an emphasis on patient-centered oral healthcare delivery across its regional footprint in Zhejiang and other locations in China. The company is headquartered in Hong Kong with operations anchored in Wenzhou, Zhejiang, and expanded facilities across multiple cities, including Rui’an and Longgang, as part of its growth strategy to broaden access to specialized dental care. Core products and services - General dentistry: comprehensive oral examinations, preventive care, routine restorative procedures, preventive dentistry, and general dental treatments. - Reparative dentistry: restorative dentistry, crowns, bridges, fillings, and other tooth-rehabilitation procedures. - Implant dentistry: dental implants, implant-supported restorations, surgical placement, and prosthetic integration. - Orthodontics and cosmetic dentistry: braces, aligners, occlusal corrections, cosmetic dental procedures, and aesthetic smile enhancements. - Pediatric dentistry: child-focused preventive and restorative dental services. - Related diagnostics and ancillary services: dental imaging, preventative care programs, and patient education initiatives. - Hospital network services: in-house dental hospitals and clinics offering multidisciplinary dental care, acute and elective procedures, and post-treatment follow-ups. Latest major company changes - Strategic expansion of hospital network: continued growth of private dental hospitals in Zhejiang, including newly integrated facilities and expanded service offerings across Wenzhou and neighboring cities. - Focus on operational efficiency and cost discipline: ongoing efforts to optimize care delivery, reduce overhead, and improve patient throughput across the network. - Product and service diversification: enhanced emphasis on implant dentistry and orthodontics, with expanded patient access through new clinic openings and upgraded clinical capabilities. - Public disclosure and listing-related activities: ongoing regulatory disclosures in connection with its offshore corporate structure and domestic Chinese healthcare subsidiaries, including updates to filings and corporate governance practices. Additional context - Industry and segments: healthcare services with a specialization in dentistry; private dental hospital networks; outpatient clinical services; dental implants and orthodontics. - Target markets: prepaid and insured dental care consumers, private pay patients, and corporate healthcare clients seeking dental services for employees. - Geographic operations: primarily China, with headquarters in Hong Kong; significant operations in Wenzhou (Lucheng, Yueqing, Rui’an, Longgang), Zhejiang province, and additional facilities within Zhejiang and surrounding regions. - Founding year and headquarters: founded in 2011; headquartered in Hong Kong, China. - Subsidiaries/structure: operates as a group with Chinese dental hospitals and clinics; related offshore structures and corporate entities connected to its listing and regulatory filings.